Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOLAR: VigantOL Oil Add-on to Rebif in RRMS
NCT01285401Phase 2Completed
- Sponsor
- Merck KGaA
- Start
- Feb 2011
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of cholecalciferol in relapsing-remitting multiple sclerosis (RRMS), sponsored by Merck KGaA. Started Feb 2011; status: completed.
02
Drugs
cholecalciferol
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01285401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01285401.